| Identification | |
| Name: | Cyclopropanecarboxamide,N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]- |
| Synonyms: | Cyclopropanecarboxylicacid N-[4-[[4-(4-methylpiperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)pyrimidin-2-yl]sulfanyl]phenyl]amide;MK 0457;VX 680; |
| CAS: | 639089-54-6 |
| Molecular Formula: | C23H28N8OS |
| Molecular Weight: | 464.59 |
| InChI: | InChI=1/C23H28N8OS/c1-15-13-20(29-28-15)25-19-14-21(31-11-9-30(2)10-12-31)27-23(26-19)33-18-7-5-17(6-8-18)24-22(32)16-3-4-16/h5-8,13-14,16H,3-4,9-12H2,1-2H3,(H,24,32)(H2,25,26,27,28,29) |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.37 g/cm3 |
| Refractive index: | 1.708 |
| Specification: |
?Tozasertib , its cas register number is 639089-54-6. It also can be called N-[4-[[4-(4-Methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide ; MK 0457 ; and VX 680 . And its?classification code is antineoplastic agents. |
| Safety Data | |
 |
|
